BRAF and colorectal carcinoma: Furthermore, when considering the combination of all the 10 bacterial species differentially represented between the two CRC groups a best performance as a biomarker signature distinguishing BRAFV600E from BRAF wt cases was reached, thus identifying potential diagnostic fecal biomarkers for CRC patients (Fig. 7g).